Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Current Status of Intestinal Failure and Intestinal Transplantation

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2012³â 15±Ç 3È£ p.127 ~ 137
°íÀ缺,
¼Ò¼Ó »ó¼¼Á¤º¸
°íÀ缺 ( Ko Jae-Sung ) 
Seoul National University College of Medicine Department of Pediatrics

Abstract


Pediatric intestinal failure occurs secondary to short bowel syndrome, motility disorders, or malabsorption. The establishment of an intestinal rehabilitation program and the introduction of innovative surgical and medical treatments, such as the serial transverse enteroplasty procedure and omega-3-containing lipid emulsions, have been major advances in the treatment of intestinal failure. Intestinal transplantation is now established as a therapeutic modality in selected children with irreversible intestinal failure. The improved short to intermediate term survival of intestinal transplant recipients in the last decade can be attributed to immunosuppression with a lymphocyte-depleting agent, control of acute cellular rejection, and comprehensive infection control with careful monitoring of viral pathogens including cytomegalovirus and Epstein-Barr virus.

Å°¿öµå

Intestinal failure; Short bowel syndrome; Intestinal transplantation; Child; Survival

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS